Misar (Alprazolam)

Alprazolam, the active ingredient in Misar, is a benzodiazepine presented as an oral dosage form for oral use. It is prescribed for generalized anxiety disorder, panic disorder and anxiety associated with depression in adult patients. GNH USA supplies Misar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Alprazolam is a benzodiazepine that acts on the central nervous system to alleviate anxiety‑related conditions. - Generalized anxiety disorder: reduces excessive worry and tension, improving daily functioning. - Panic disorder: diminishes the frequency and intensity of panic attacks. - Anxiety associated with depression: eases co‑occurring anxiety symptoms, supporting overall mood stabilization.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of light‑headedness or unsteadiness. - Impaired coordination: reduced motor control or clumsiness. - Memory disturbances: difficulty recalling recent events. - Mood changes: irritability or mild depression. - Gastrointestinal upset: nausea or abdominal discomfort.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, especially with other depressants. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Dependence or withdrawal: signs of physical or psychological dependence after prolonged use. - Paradoxical aggression: increased hostility or agitation. - Suicidal thoughts: emergence of suicidal ideation or behavior. - Hepatic dysfunction: abnormal liver enzymes or jaundice.

Before prescribing alprazolam, clinicians should consider several safety factors. - Pregnancy: Category D – potential risk to the fetus; avoid unless benefits outweigh risks. - Breastfeeding: excreted in milk; assess risk versus benefit for nursing infants. - Elderly patients: increased sensitivity; start with the lowest effective dose. - Concomitant CNS depressants: risk of enhanced sedation and respiratory depression. - History of substance abuse: potential for dependence; monitor closely. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Alprazolam may interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Opioids (e.g., morphine, oxycodone): additive respiratory depression. - Barbiturates (e.g., phenobarbital): profound CNS depression. - Antifungals (e.g., ketoconazole): increased alprazolam plasma levels. - Macrolide antibiotics (e.g., erythromycin): elevated drug concentrations. - HIV protease inhibitors (e.g., ritonavir): heightened sedation risk.

Moderate Interactions (Monitor Closely): - Antidepressants (e.g., fluoxetine, sertraline): may increase sedation. - Antihistamines (e.g., diphenhydramine): additive drowsiness. - Alcohol: enhances CNS depressant effects. - Anticonvulsants (e.g., carbamazepine): may reduce alprazolam levels. - Cimetidine: modest increase in drug exposure.